CUSIP: 45782C102
Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / IBD 50 ETF
-
Total 13F shares
-
1,201,575
-
Share change
-
-30,718
-
Total reported value
-
$50,336,084
-
Price per share
-
$41.05
-
Number of holders
-
62
-
Value change
-
-$704,377
-
Number of buys
-
23
-
Number of sells
-
28
Quarterly Holders Quick Answers
What is CUSIP 45782C102?
CUSIP 45782C102 identifies FFTY - INNOVATOR ETFS TRUST - IBD 50 ETF in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2021
-
Previous quarter:
Q3 2020
Recent filing periods for CUSIP 45782C102:
Institutional Holders of INNOVATOR ETFS TRUST - IBD 50 ETF (FFTY) as of Q4 2020
As of 31 Dec 2020,
INNOVATOR ETFS TRUST - IBD 50 ETF (FFTY) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,201,575 shares.
The largest 10 holders included
Chicago Partners Investment Group LLC, LPL Financial LLC, WELLS FARGO & COMPANY/MN, RAYMOND JAMES & ASSOCIATES, D.A. DAVIDSON & CO., ADVISOR GROUP HOLDINGS, INC., ROYAL BANK OF CANADA, Cetera Investment Advisers, Cambridge Investment Research Advisors, Inc., and Tradition Wealth Management, LLC.
This page lists
62
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.